HIV coinfection with hepatitis b screening: Difference between revisions
No edit summary |
m Changes made per Mahshid's request |
||
| Line 11: | Line 11: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 18:01, 18 September 2017
|
HIV coinfection with hepatitis b Microchapters |
|
Differentiating HIV coinfection with hepatitis b from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV coinfection with hepatitis b screening On the Web |
|
American Roentgen Ray Society Images of HIV coinfection with hepatitis b screening |
|
Directions to Hospitals Treating HIV coinfection with hepatitis b |
|
Risk calculators and risk factors for HIV coinfection with hepatitis b screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Screening
For HIV infected individuals with chronic HBV, additional screening for coinfection with HCV is recommended; hepatocellular carcinoma screening with alpha fetoprotein and imaging of liver every 6 months is being suggested by some but the cost benefit of one or both tests as well as the frequency of monitoring in various health economies remain to be assessed. [1]
References
- ↑ Thio CL (2009). "Hepatitis B and human immunodeficiency virus coinfection". Hepatology. 49 (5 Suppl): S138–45. doi:10.1002/hep.22883. PMID 19399813. Retrieved 2012-03-29. Unknown parameter
|month=ignored (help)